Does the completeness of prostate sampling predict outcome for patients undergoing radical prostatectomy?: data from...

Area of Science:

• Urology
• Oncology
• Pathology

Background:

• Radical prostatectomy (RP) is a primary treatment for prostate cancer.
• Accurate prediction of patient outcomes after RP is crucial for treatment planning and monitoring.
• Pathologic examination of the surgical specimen is key to staging and prognosis.

Purpose of the Study:

• To evaluate if more complete sampling of the radical prostatectomy specimen enhances the prediction of patient outcomes.
• To compare outcomes between step-sectioned and non-step-sectioned RP specimens.

Main Methods:

• A review of pathology reports from 1383 prostate cancer patients who underwent RP was conducted.
• Specimens were categorized as step-sectioned (entire specimen submitted, sections ≤0.5 cm) or non-step-sectioned.
• Outcomes, including prostate-specific antigen (PSA) recurrence and secondary cancer treatment, were compared between groups using Kaplan-Meier analysis.

Main Results:

• No significant differences in pathologic stage, Gleason score, or margin status were observed between step-sectioned and non-step-sectioned groups.
• Patients undergoing step-sectioning had lower PSA at diagnosis.
• While overall PSA recurrence and secondary treatment rates did not differ, patients with negative margins in the step-sectioned group showed significantly lower nonadjuvant treatment use and a trend towards lower PSA recurrence.

Conclusions:

• More complete pathologic analysis of RP specimens may offer better outcome prediction for select patients.
• Further research is necessary to determine if the benefits of routine step-sectioning outweigh the required resources.